These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19181274)

  • 1. Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p-iodoamphetamine.
    Kawai K; Nishii R; Shikano N; Makino N; Kuga N; Yoshimoto M; Jinnouchi S; Nagamachi S; Tamura S; Takamura N
    Nucl Med Biol; 2009 Jan; 36(1):99-106. PubMed ID: 19181274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive displacement of serum protein binding of radiopharmaceuticals with amino acid infusion investigated with N-isopropyl-p-123I-iodoamphetamine.
    Kuga N; Shikano N; Takamura N; Nishii R; Yamasaki K; Kobayashi M; Nagamachi S; Tamura S; Kawai K
    J Nucl Med; 2009 Aug; 50(8):1378-83. PubMed ID: 19617322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
    Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
    Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-isopropyl-4-[123I]iodoamphetamine (123I-IMP) products: a difference in radiochemical purity, unmetabolized fraction, and octanol extraction fraction in arterial blood and regional brain uptake in rats.
    Kanai Y; Hasegawa S; Kimura Y; Oku N; Ito H; Fukuda H; Hatazawa J
    Ann Nucl Med; 2007 Sep; 21(7):387-91. PubMed ID: 17876551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
    Soma LR; Uboh CE; Rudy JA; Smith MS
    Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method.
    Nishi K; Kobayashi M; Nishii R; Shikano N; Takamura N; Kuga N; Yamasaki K; Nagamachi S; Tamura S; Otagiri M; Kawai K
    Nucl Med Biol; 2013 Apr; 40(3):366-70. PubMed ID: 23312701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective protein binding of tetrahydropalmatine enantiomers in human plasma, HSA, and AGP, but not in rat plasma.
    Sun DL; Huang SD; Wu PS; Li J; Ye YJ; Jiang HD
    Chirality; 2010 Jun; 22(6):618-23. PubMed ID: 19927376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the serum protein binding of prazosin in man and rat.
    Dale O; Nilsen OG
    Biochem Pharmacol; 1984 Jun; 33(11):1719-24. PubMed ID: 6732841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
    Brunner F; Müller WE
    J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
    Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding protein of erythromycin in human serum.
    Dette GA; Knothe H
    Biochem Pharmacol; 1986 Mar; 35(6):959-66. PubMed ID: 3954799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride.
    Zsila F; Fitos I; Bikádi Z; Simonyi M; Jackson HL; Lockwood SF
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5357-66. PubMed ID: 15454227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.
    Gokara M; Kimavath GB; Podile AR; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(1):196-210. PubMed ID: 24359035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducible and time-dependent modification of serum protein binding in Wistar Kyoto rats.
    van Steeg TJ; Krekels EH; Danhof M; de Lange EC
    J Pharmacol Toxicol Methods; 2007; 56(1):72-8. PubMed ID: 17376707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA.
    Pillinger MH; Dinsell V; Apsel B; Tolani SN; Marjanovic N; Chan ES; Gomez P; Clancy R; Chang LF; Abramson SB
    Br J Pharmacol; 2004 Jul; 142(6):973-82. PubMed ID: 15210577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.